Yu, I.; Park, S.; Hong, S.H.; Chang, M.-S.; Lee, S.J.; Yong, S.J.; Lee, W.-Y.; Kim, S.-H.; Lee, J.-H.
Risk of Tuberculosis Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Study. J. Pers. Med. 2022, 12, 1189.
https://doi.org/10.3390/jpm12071189
AMA Style
Yu I, Park S, Hong SH, Chang M-S, Lee SJ, Yong SJ, Lee W-Y, Kim S-H, Lee J-H.
Risk of Tuberculosis Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Study. Journal of Personalized Medicine. 2022; 12(7):1189.
https://doi.org/10.3390/jpm12071189
Chicago/Turabian Style
Yu, Iseul, Sunmin Park, Se Hwa Hong, Min-Seok Chang, Seok Jeong Lee, Suk Joong Yong, Won-Yeon Lee, Sang-Ha Kim, and Ji-Ho Lee.
2022. "Risk of Tuberculosis Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Study" Journal of Personalized Medicine 12, no. 7: 1189.
https://doi.org/10.3390/jpm12071189
APA Style
Yu, I., Park, S., Hong, S. H., Chang, M. -S., Lee, S. J., Yong, S. J., Lee, W. -Y., Kim, S. -H., & Lee, J. -H.
(2022). Risk of Tuberculosis Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Study. Journal of Personalized Medicine, 12(7), 1189.
https://doi.org/10.3390/jpm12071189
